Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Fibrolamellar hepatocellular carcinoma × Leuprolide × 1 year × Clear all

Sponsor

Conditions

Prostatic Neoplasms 46 Breast Neoplasms 8 Salivary Gland Neoplasms 2 Prostate Adenocarcinoma 2 Breast Neoplasms, Male 2 Stage I Prostate Adenocarcinoma AJCC v7 1 Salivary Gland Neoplasm Duct 1 Primary Dysautonomias 1 Patient Compliance 1 PSA Level Greater Than Two 1 Newly Diagnosed Oligometastatic Prostate Cancer 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia 1 Kidney Diseases 1 Hypertension 1 Hormone Sensitive Prostate Cancer 1 Hereditary Sensory and Autonomic Neuropathies 1 HER2-positive Breast Cancer 1 Granulosa cell tumor of the ovary 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma 1

Interventions

Nivolumab 3 poly ICLC 2 Specimen Handling 2 Sorafenib 2 Irinotecan 2 Ipilimumab 2 sapanisertib 1 pembrolizumab 1 durvalumab 1 dostarlimab 1 dehydroftorafur 1 atezolizumab 1 aflibercept 1 Watchful Waiting 1 Vincristine 1 Surveys and Questionnaires 1 Platinum 1 Oxaliplatin 1 Observation 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 DT2216 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Bevacizumab 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡